The Centers for Medicare and Medicaid Services
(CMS) proposed the Hospital Inpatient
Prospective Payment System rule (IPPS) in the
Tuesday, April 25, 2006 Federal Register.
Proposed changes for FY 2007 include the use
of a hospital-specific relative value cost center
weighting methodology to adjust DRG relative
weights, and in FY 2008 if not sooner, the use of
consolidated severity-adjusted DRGs or other
severity adjustment methods. The final rule will
also implement changes made by the Deficit
Reduction Act of 2005, and calls for a full market
basket increase of 3.4 percent for inpatient
hospital services in FY’07. The final rule will be
issued on August 1, 2006, and all changes will
apply to discharges made on or after October 1,
2006.
| HCPCS/CPT |
Short Descriptor |
Payment Rate |
| Q9945 |
LOCM up to 149 mg/ml iodine, 1ml |
0.37 |
| Q9946 |
LOCM 150-199mg/ml iodine,1ml |
1.84 |
| Q9947 |
LOCM 200-249mg/ml iodine,1ml |
1.42 |
| Q9948 |
LOCM 250-299mg/ml iodine,1ml |
0.26 |
| Q9949 |
LOCM 300-349mg/ml iodine,1ml |
0.34 |
| Q9950 |
LOCM 350-399mg/ml iodine,1ml |
0.21 |
| Q9951 |
LOCM 400 or greater mg/ml iodine, per mL |
0.30 |
| Q9952 |
Inj Gad-base MR contrast,1ml |
2.89 |
| Q9953 |
Inj Fe-based MR contrast,1ml |
30.41 |
| Q9954 |
Oral MR contrast, 100 ml |
8.69 |
| Q9955 |
Inj perflexane lip micros,ml |
7.05 |
| Q9956 |
Inj octafluoropropane mic,ml |
49.61 |
| Q9957 |
Inj perflutren lip micros,ml |
61.72 |
| Q9958 |
HOCM up to 149 mg/ml iodine, 1ml |
0.08 |
| Q9959 |
HOCM 150-199mg/ml iodine,1ml |
-- |
| Q9960 |
HOCM 200-249mg/ml iodine,1ml |
0.10 |
| Q9961 |
HOCM 250-299mg/ml iodine,1ml |
0.27 |
| Q9962 |
HOCM 300-349mg/ml iodine,1ml |
0.13 |
| Q9963 |
HOCM 350-399mg/ml iodine,1ml |
0.43 |
| Q9964 |
HOCM 400 or greater mg/ml iodine, per mL |
0.17 |
Note: GE Healthcare is discontinuing the “vascular” and “cystographic” forms
of Hypaque™ (diatrizoate). The oral formulation of HYPAQUE will
not be eliminated.
HYPAQUE will be sold until the supply is depleted.